Acceleron Pharma Overview

Acceleron Pharma Operating Income

Operating Income for XLRN.

Quarterly Operating Income

$-70630000.00

↑ 80.05% YoY

As of Sep 30, 2021

Annual Operating Income (TTM)

$-255488000.00

↑ 88.84% YoY

Trailing 12 months ending Sep 30, 2021

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin